Mrs
Rachel
Fetches

Partner & IP Solicitor

London Office

Telephone. +44(0) 207 776 5111
Mobile. +44(0) 782 790 9139
Email. [email protected]

Experience

Rachel is an IP/Patent Litigation Partner and advises on contentious intellectual property matters for clients across a broad range of sectors including, life sciences, pharmaceuticals, healthcare, chemicals, food and beverage, aviation, media and telecommunications industries. She has extensive experience of litigating before the UK Patents Court, High Court and Court of Appeal. She has also regularly advised in relation to pan-European IP litigation strategy for both patents and trade marks.

Specialisms

  • Catalysis
  • Electrochemistry
  • Energy
  • Food science
  • Household products
  • Material science
  • Petrochemicals
  • Pharmaceutical technologies
  • Physical chemistry
  • Polymer chemistry
  • Printing technologies
  • Law
  • Agbio
  • Anti infectives
  • Bioinformatics
  • Bioprocessing
  • Cell and gene therapy
  • Diagnostics
  • Food technology
  • Gene editing technologies
  • Immunobiology
  • Microbiome
  • Personalised medicine

Industries

  • Creative, media & entertainment icon Creative, media & entertainment
  • Food & drink icon Food & drink
  • Healthcare icon Healthcare
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Copyright & database rights
  • Due diligence
  • In-house legal support
  • IP litigation
  • Patent term extensions & SPCs
  • Patents
  • Portfolio management
  • Strategy
  • Trade marks

Qualifications

Solicitor

England & Wales
Ireland
Republic of Ireland


BSC

Cell Biotechnology (Spec)

MA

Health Care Ethics

OTHER

PgDL/LPC College of Law

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property Law

Recognition

MIP Stars Handbook 2016

“Rachel is an accomplished patent litigator with an excellent pedigree in life sciences” says a peer

IAM Patent 1000

“Rachel Fetches is the woman to go to. Her weighty workload includes substantial matters such as representing Accord Healthcare against Research Technologies a complex case that has involved expert testimony from US federal law and Texas state law experts”

Legal500, London: Intellectual Property - patents (contentious and non-contentious)

HGF Limited’s patent litigators have strength in the life sciences sector, as evidenced by Rachel Fetches’ representation of multinational generic pharmaceuticals companies in patent infringement defence and oppositions.

View recognition online

Publications

A new dawn for SPCs

View publication online

UK Supreme Court invalidates Regeneron's transgenic mouse patents for lack of sufficiency

View publication online

SKY Trade Marks applied for to use purely as “Legal Weapon” are held to be invalid

View publication online

HGF wins Scottish “Firm of the Year” for Prosecution at the MIP Awards

View publication online

The end of the UPC as we know it?

View publication online

SkyKick ruling

View publication online

Clearing out the clutter – SkyKick may open up trade mark registers Across Europe

View publication online

The Vedanta Opposition: A healthy sign of a maturing industry

View publication online

Test for obviousness for dosage patents clarified by the Supreme Court

View publication online

A new dawn for SPCs

View publication online

UK Supreme Court invalidates Regeneron's transgenic mouse patents for lack of sufficiency

View publication online

SKY Trade Marks applied for to use purely as “Legal Weapon” are held to be invalid

View publication online

The end of the UPC as we know it?

View publication online

Skykick ruling

View publication online

Test for obviousness for dosage patents clarified by the Supreme Court

View publication online

Clearing out the clutter – SkyKick may open up trade mark registers Across Europe

View publication online

Conferences: 2021

March 2nd 2021

MIP International Patent Forum

Attended

Event details

February 9th 2021

HGF IP in Healthcare Virtual Conference

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Conferences: 2020

November 2nd 2020

AIPPI Congress London

Attended

Event details

Conferences: 2019

November 26th 2019

IQPC Lifesciences in IP

Attended

Event details

November 26th 2019

IQPC Life Science IP 2019 - London

Attended

Event details

November 21st 2019

Life Sciences Patent Network

Attended

Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

March 19th 2019

HGF IP in Healthcare Conference

Speaker

Event details

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester

Speaker

Event details

Conferences: 2018

November 27th 2018

IQPC Life Sciences IP Conference

Speaker

Event details

Related News

EPO Enlarged Board of Appeal decision G4/19 - a European patent application can be refused by reason of the prohibition on double patenting

The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’.  Such a refusal can …

Read article

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

Searching for the distinctive

How to streamline the trade mark selection process by conducting effective, in-house ‘dirty searches’. Selecting the right trade mark for your new healthcare product is a critically important task. Consumers …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.